Overview

To Evaluate the Bioavailability of a Tablet of AZD1656

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the bioavailability of a tablet of AZD1656.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca